Search Results

You searched for : biopharmaceuticals

	Prime Minister Modi inaugurated the biotech startup Expo 2022, praising the sector's rapid growth The Biotech Startup Expo 2022 will provide a common platform to connect investors, entrepreneurs, scientists, researchers, industry leaders, manufacturers, bio-incubators, regulators and government officials.... Jun 11
	AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity Latest pharma update... Sep 27
	Success story of Aurobindo Pharma In the period between 1988-89, the company only manufactured penicillin. They have since then expanded into antibiotics, anti-allergic, antiretrovirals, cardiovascular, central nervous system ... Sep 21
	Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease.... Jul 17
	Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease... Jun 28
	COVID-19 Vaccine AstraZeneca effective against Delta (â€˜Indianâ€™) variant Real-world data demonstrated 92% vaccine effectiveness against hospitalisations due to the Delta variant ... Jun 16
	US may not use AstraZeneca vaccine , Dr Anthony Fauci WHO found that a causal relationship between the vaccines and blood clotting events is considered plausible but is not confirmed... Apr 10
	New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms The latest studies claim 76% efficacy, DSMB still has doubts... Mar 25
	Pfizer and Moderns pledges US Govt for 240 million doses of vaccine by March end J&J also applied for emergency application... Feb 24
	Cabinet approves production linked incentive scheme for pharmaceuticals The Scheme will benefit domestic manufacturers, help in creating employment and is expected to contribute to the availability of wider range of affordable medicines for ... Feb 24
	Farxiga granted Priority Review in the US for the treatment of patients with chronic kidney disease Farxiga could become the first SGLT2 inhibitor approved to treat patients with chronic kidney disease, with and without type-2 diabetes... Jan 06
	Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma Tezepelumabâ€™s effect on other efficacy parameters was similar to those observed in previous trials, including the registrational Phase III NAVIGATOR trial.... Dec 22
	COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021 COVAX, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating ... Dec 19
	Trixeo Aerosphere approved in the EU for maintenance treatment of COPD COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ... Dec 14
	100% we canâ€™t prevent errors but we can reduce the error says Jagan Mohan Reddy, Senior Software Quality Assurance Engineer, GE Healthcare ... Dec 10
	Crestor to be divested to GrÃ¼nenthal in Europe AstraZeneca has agreed to sell the rights to Crestor and associated medicines in over 30 countries in Europe, except the UK and Spain.... Dec 01
	Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis The NMPA has approved a dosing label update in China for AstraZenecaâ€™s Lokelma to include patients with hyperkalaemia on chronic haemodialysis.... Nov 25
	AstraZeneca starts new COVID-19 prevention trials of antibody cocktail. The Phase III international clinical trial will recruit a total of 5,000 people across countries in Europe and the United States to assess the ... Nov 21
	Prestige Biopharma and Teva Israel signs license and supply agreement for Prestige's Trastuzumab Biosimilar in Israel Tuznue is a mAb biosimilar to Rocheâ€™s Herceptin (trastuzumab)... Nov 13
	Bio and Pharma Integrates 2020: Live Online 16 & 17 November 2020 The digital networking space offers real-time, face-to-face engagement, which maximises chance encounters with other attendees... Nov 12
	Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma AstraZeneca and Amgen today announced positive results from the new medicine tezepelumab in patients with severe, uncontrolled asthma.... Nov 10
	Brilinta approved in the US to reduce the risk of stroke in patients with an acute ischaemic stroke or high-risk transient ischaemic attack New indication expands use of Brilinta beyond the cardiovascular disease to patients with mild-to-moderate stroke... Nov 06
	Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma PONENTE Phase IIIb open-label trial showed Fasenra eliminated the use of maintenance oral corticosteroids in OCS-dependent asthma patients with a broad range of ... Oct 29
	AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined For roxadustat, more than 40 abstracts present safety and efficacy outcomes in anaemia of chronic kidney disease ... Oct 20
	There is light at the end of the tunnel, which stands right for every business but till then we need to work the length of the tunnel to reach our goals saysÂ Dr. C. Omprakash Ph.D., Technical Director & Partner, Vyomus Consulting ... Oct 20
25 Matching result(s) found!

-Advertisements-

Trending Now
	Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
	Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
	IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
	Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
	Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
	Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
	Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
	Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023
	IIIT-Hyderabad among top 100 institutions for 5G Use Case LabNovember 17, 2023
	Powerful, motivating and inspiring talks marked TEDx Hyderabad Women 2023 which was held with the theme "Two Steps ForwardNovember 17, 2023
	Speaking the Diagnosis: How AI in Voice Analysis Is Revolutionizing Diabetes DetectionNovember 17, 2023
	FDA Approves Zepbound: A New Medication for Weight Loss by Eli LillyNovember 17, 2023
	CoverSelf Raises $8.2 Million in Seed Funding to Revolutionize Healthcare Claims with Innovative Fintech PlatformNovember 16, 2023
	From Miracle to Medic: The Extraordinary Journey of India's First Paediatric Liver Transplant RecipientNovember 16, 2023
	Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India LaunchNovember 16, 2023
	Global Corporate Summit 2023 with the theme Unlocking Opportunities in a Dynamic World heldNovember 16, 2023
	2nd IHub-Data Mobility Summit heldNovember 16, 2023
	Revolutionary AI-powered technology detects multiple abdominal pathologies simultaneouslyNovember 16, 2023
	1 Out of 3 Stroke Patients Suffer Long-Term Health Complications, Says NeurologistNovember 16, 2023
	Amrita Hospital, Kochi, Launches App for People with Swallowing DifficultiesNovember 15, 2023

Search Results

Prime Minister Modi inaugurated the biotech startup Expo 2022, praising the sector's rapid growth

AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity

Success story of Aurobindo Pharma

Status on FDA Advisory Committee vote on roxadustat in anaemia of chronic kidney disease

Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease

COVID-19 Vaccine AstraZeneca effective against Delta (â€˜Indianâ€™) variant

US may not use AstraZeneca vaccine , Dr Anthony Fauci

New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms

Pfizer and Moderns pledges US Govt for 240 million doses of vaccine by March end

Cabinet approves production linked incentive scheme for pharmaceuticals

Farxiga granted Priority Review in the US for the treatment of patients with chronic kidney disease

Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma

COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021

Trixeo Aerosphere approved in the EU for maintenance treatment of COPD

100% we canâ€™t prevent errors but we can reduce the error says Jagan Mohan Reddy, Senior Software Quality Assurance Engineer, GE Healthcare

Crestor to be divested to GrÃ¼nenthal in Europe

Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis

AstraZeneca starts new COVID-19 prevention trials of antibody cocktail.

Prestige Biopharma and Teva Israel signs license and supply agreement for Prestige's Trastuzumab Biosimilar in Israel

Bio and Pharma Integrates 2020: Live Online 16 & 17 November 2020

Tezepelumab NAVIGATOR Phase III trial met primary endpoint of a statistically significant and clinically meaningful reduction in exacerbations in a broad population of patients with severe asthma

Brilinta approved in the US to reduce the risk of stroke in patients with an acute ischaemic stroke or high-risk transient ischaemic attack

Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma

AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined

There is light at the end of the tunnel, which stands right for every business but till then we need to work the length of the tunnel to reach our goals saysÂ Dr. C. Omprakash Ph.D., Technical Director & Partner, Vyomus Consulting

Trending Now